GlassScriptPhysician profile
Andrew A Freiberg
NPI 1144210956
$5,904,745.67
in general payments reported to CMS, 2019-2025
6 companies · $53K in 2025
The $53K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5.5M · 2020: $47K · 2021: $137K · 2022: $75K · 2023: $48K · 2024: $38K · 2025: $53K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $131K · Travel and Lodging: $4,470 · Food and Beverage: $3,444 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,400.00 |
| Travel and Lodging | $4,469.64 |
| Food and Beverage | $3,443.91 |
| Education | $127.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $5,852,140.41 | 2019-2025 | Persona, Oxford Partial Knee, Vanguard Complete Knee Solution |
| Anika Therapeutics, INC. | $35,501.17 | 2020-2021 | |
| Stryker Corporation | $16,367.70 | 2023-2025 | Mako, Triathlon, Insignia |
| Total Joint Orthopedics, INC. | $483.14 | 2021-2025 | |
| Smith+Nephew, INC. | $253.25 | 2022-2023 | Ri Hip Navigation, Polarstem, Or3o Dual Mobility |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$35,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Freiberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.